These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
185 related items for PubMed ID: 6205774
1. Macrophage-activating factor for cytotoxicity produced by a human T-cell hybridoma. Higuchi M, Nakamura N, Tsuchiya SI, Kobayashi Y, Osawa T. Cell Immunol; 1984 Sep; 87(2):626-36. PubMed ID: 6205774 [Abstract] [Full Text] [Related]
2. Human macrophage-activating factors for cytotoxicity. I. Establishment of a human T-cell hybridoma that produces macrophage-activating factors for cytotoxicity. Higuchi M, Sugimoto M, Kobayashi Y, Osawa T. Microbiol Immunol; 1987 Sep; 31(5):469-79. PubMed ID: 3116371 [Abstract] [Full Text] [Related]
3. Human T-cell hybridomas producing migration inhibitory factor and macrophage activating factors. Higuchi M, Asada M, Kobayashi Y, Osawa T. Cell Immunol; 1983 Jun; 78(2):257-65. PubMed ID: 6305517 [Abstract] [Full Text] [Related]
4. T-cell hybridoma production of macrophage activation factor (MAF) I. Separation of MAF from interferon gamma. Ratliff TL, Thomasson DL, McCool RE, Catalona WJ. J Reticuloendothel Soc; 1982 May; 31(5):393-7. PubMed ID: 6181257 [Abstract] [Full Text] [Related]
5. Activation of human monocyte cytotoxicity by natural and recombinant immune interferon. Le J, Prensky W, Yip YK, Chang Z, Hoffman T, Stevenson HC, Balazs I, Sadlik JR, Vilcek J. J Immunol; 1983 Dec; 131(6):2821-6. PubMed ID: 6417232 [Abstract] [Full Text] [Related]
9. Phenotypic characterization of human T lymphocyte populations producing macrophage-activating factor (MAF) lymphokines. Biondi A, Roach JA, Schlossman SF, Todd RF. J Immunol; 1984 Jul; 133(1):281-5. PubMed ID: 6373929 [Abstract] [Full Text] [Related]
10. Constitutive production of novel macrophage-activating factor(s) by human T cell hybridomas. Taniyama T, Taki S, Akiyama Y, Yoshizawa K, Hamuro J, Arai K, Wong GG. Clin Invest Med; 1990 Dec; 13(6):305-12. PubMed ID: 2127737 [Abstract] [Full Text] [Related]
11. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages. Nakajima H, Fujiwara H, Takai Y, Izumi Y, Sano S, Tsuchida T, Hamaoka T. J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520 [Abstract] [Full Text] [Related]
12. Identification of a T cell hybridoma that produces large quantities of macrophage-activating factor. Schreiber RD, Altman A, Katz DH. J Exp Med; 1982 Sep 01; 156(3):677-89. PubMed ID: 7050288 [Abstract] [Full Text] [Related]
13. Identification of human T cell hybridoma-derived macrophage activating factor as interleukin-2. Higashi N, Higuchi M, Hanada N, Oeda J, Kobayashi Y, Osawa T. J Biochem; 1993 Jun 01; 113(6):715-20. PubMed ID: 8370669 [Abstract] [Full Text] [Related]
14. Lymphocyte supernatant-induced human monocyte tumoricidal activity: dependence on the presence of gamma-interferon. Sadlik JR, Hoyer M, Leyko MA, Horvat R, Parmely M, Whitacre C, Zwilling B, Rinehart JJ. Cancer Res; 1985 May 01; 45(5):1940-5. PubMed ID: 3921233 [Abstract] [Full Text] [Related]
15. Identification and characterization of a human T cell line-derived lymphokine with MAF-like activity distinct from interferon-gamma. Lee JC, Rebar L, Young P, Ruscetti FW, Hanna N, Poste G. J Immunol; 1986 Feb 15; 136(4):1322-8. PubMed ID: 3003193 [Abstract] [Full Text] [Related]